Trial · NCT07907614
Comparison of GMI, PNF, and Standard Care for Post-Traumatic Elbow Stiffness Rehabilitation in Adults
NCT07907614, Not applicable, Not yet recruiting, Centre Hospitalier de Valenciennes
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Comparison of GMI, PNF, and Standard Care for Post-Traumatic Elbow Stiffness Rehabilitation in Adults. Trials, record NCT07907614. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07907614
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Comparison of GMI, PNF, and Standard Care for Post-Traumatic Elbow Stiffness Rehabilitation in Adults
- NCT number
- NCT07907614
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 75 participants, estimated
- Lead sponsor
- Centre Hospitalier de Valenciennes
- Conditions
- Elbow Stiffess, Rehabilitation Treatment
- Interventions
- Standard Multidisciplinary Rehabilitation, Graded Motor Imagery (GMI), Proprioceptive Neuromuscular Facilitation (PNF) - Hold-Relax
- First posted
- 2026-10-30
- Last updated
- 2026-10-30
Source ClinicalTrials.gov
Registered outcomes13
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Upper-limb functional capacity assessed by the DASH score at 6 weeks | 6 weeks after treatment initiation | Upper-limb functional capacity will be assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire. The DASH score at 6 weeks will be compared between the three study groups, with adjustment for the baseline DASH score. |
| Secondary | Upper-limb functional capacity assessed by the DASH score at 3 months after treatment | 3 months after the end of treatment (18 weeks after inclusion) | Upper-limb functional capacity will be assessed using the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire to evaluate the maintenance of treatment effects and compare the three study groups. |
| Secondary | Isometric elbow flexor and extensor muscle strength at 6 weeks | 6 weeks after treatment initiation | Isometric strength of the elbow flexor and extensor muscles will be measured and compared between the three study groups. |
| Secondary | Isometric elbow flexor ans extensor muscle strength at 3-month follow-up | 3 months after the end of treatment (18 weeks after inclusion) | Isometric strength of the elbow flexor and extensor muscles will be measured to assess the maintenance of treatment effects and compared between the three study groups. |
| Secondary | Active elbow and forearm range of motion at 6 weeks | 6 weeks after treatment initiation | Active elbow flexion and extension and forearm pronation and supination will be measured to assess changes in joint range of motion. |
| Secondary | Active elbow and forearm range of motion at 3-month follow-up | 3 months after the end of treatment (18 weeks after inclusion) | Active elbow flexion and extension and forearm pronation and supination will be measured to assess the maintenance of treatment effects. |
| Secondary | Pain intensity before and after rehabilitation sessions | Before and immediately after each rehabilitation session during the 6-week treatment period | Pain intensity will be assessed using a 0-10 numeric rating scale immediately before and after each rehabilitation session. The difference between pre-session and post-session pain scores will be assessed. |
| Secondary | Pain intensity at 6 weeks | 6 weeks after treatment initiation | Pain intensity will be assessed using a 0-10 numeric rating scale to compare pain at the end of the treatment period between the three study groups. |
| Secondary | Pain intensity at 3-month follow-up | 3 months after the end of treatment (18 weeks after inclusion) | Pain intensity will be assessed using a 0-10 numeric rating scale to evaluate the maintenance of treatment effects. |
| Secondary | Kinesiophobia assessed by the short TAMPA scale at 6 weeks | 6 weeks after treatment initiation | Kinesiophobia will be assessed using the short version of the Tampa Scale to compare the effects of the three rehabilitation protocols after treatment. |
1 to 10 of 13Source ClinicalTrials.gov
See all 13 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers9
The papers the trial lists on ClinicalTrials.gov.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07907614
GET https://conductscience.org/api/trials/v1/NCT07907614/registered